Covance's competitors

Covance's competitors include Evotec, Sartorius Stedim BioOutsource, Charles River Laboratories International and Mitra Biotech
Add company...
Covance
Covance, the drug development business of Laboratory Corporation of America Holdings (LabCorp), is the world's most comprehensive drug development company.
Evotec
Evotec is a drug discovery alliance and development partnership company focused on rapidly progressing innovative product approaches with leading pharmaceutical and biotechnology companies.
Sartorius Stedim BioOutsource
Sartorius Stedim BioOutsource is a provider of contract testing services to the biopharmaceutical and biotechnology industries.
Charles River Laboratories International
Charles River Laboratories, Inc., is a corporation specializing in a variety of pre-clinical and clinical laboratory services for the pharmaceutical, medical device, and biotechnology industries
Mitra Biotech
Mitra is a biotechnology company focused on discovering tools to segregate patients for existing and developing anti-cancer treatments.
Founding Date
Founding Date
1968
Founding Date
1993
Founding Date
2007
Founding Date
1947
Founding Date
2009
Type
Type
Subsidiary
Type
Public
Type
Private
Type
Public
Type
Private
Tags
Locations
Locations
Princeton, US HQ
Locations
Hamburg, DE HQ
Toulouse, FR
Göttingen, DE
Planegg, DE
Milton, GB
Manchester, GB
Branford, US
see more
Locations
Glasgow City, GB HQ
Locations
Wilmington, US HQ
Locations
Woburn, US HQ
Bengaluru, IN
Employees
Employees
9,495
Employees
1,316 6% increase
Employees
135
Employees
11,000
Employees
96 7% increase
Valuation ($)
Valuation ($)
N/A
Valuation ($)
1.2 b
Valuation ($)
N/A
Valuation ($)
5.1 b
Valuation ($)
N/A
Facebook followers
Facebook followers
3.6 k
Facebook followers
99
Facebook followers
N/A
Facebook followers
16.4 k
Facebook followers
1.1 k
Twitter followers
Twitter followers
7.8 k
Twitter followers
N/A
Twitter followers
774
Twitter followers
6.7 k
Twitter followers
153

Financial

Revenue (est.)
Revenue (est.)
$2.6b (FY, 2013)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$1.7b (FY, 2016)
Revenue (est.)
N/A
Net income
Net income
$179.2m (FY, 2013)
Net income
N/A
Net income
N/A
Net income
$156.4m (FY, 2016)
Net income
N/A
For sources of this data, please see the company profileDownload Excel

View company profiles